Mar 25, 2022 08:02AM
Mar 14, 2022 08:07AM
Jan 12, 2022 08:02AM
May 20, 2021 07:37AM
Apr 12, 2021 07:35AM
Mar 25, 2021 09:11AM
Mar 2, 2021 04:03PM Cantor Fitzgerald Starts Heat Biologics (HTBX) at Overweight
Feb 9, 2021 09:28AM
Feb 9, 2021 07:32AM
Dec 28, 2020 06:06AM
Oct 7, 2020 07:34AM
Sep 2, 2020 07:35AM
May 29, 2020 08:16AM
May 27, 2020 08:04AM Heat Biologics (HTBX) Announces Collaboration with Waisman Biomanufacturing to Manufacture COVID-19 Vaccine
May 11, 2020 08:13AM
Jan 21, 2020 04:05PM
Jan 16, 2020 09:53AM
Jan 16, 2020 09:50AM
Jan 13, 2020 07:19AM
Dec 16, 2019 07:08AM
Nov 18, 2019 08:20AM Heat Biologics (HTBX) Announces Additional Top Line Phase 2 Data of HS-110 plus Nivolumab in Advanced NSCLC Patients at AACR
Nov 11, 2019 07:05AM
Nov 5, 2019 08:17AM
Nov 5, 2019 08:13AM
Oct 25, 2019 04:33PM
Oct 4, 2019 04:33PM
Jul 9, 2019 08:11AM
Jun 3, 2019 07:16AM Heat Biologics (HTBX) Reports Promising Interim Phase 2 Lung Cancer Data Investigating HS-110 in Combination with Nivolumab (Opdivo)
Feb 28, 2019 05:23PM
Feb 26, 2019 09:23AM
Feb 26, 2019 07:11AM
Jan 14, 2019 08:15AM
Jan 10, 2019 07:33AM
Jun 26, 2018 07:03AM
May 7, 2018 05:10PM Heat Biologics, Inc. Announces Closing of $20.7 Million Public Offering
May 3, 2018 08:37AM
May 3, 2018 08:30AM
May 2, 2018 04:18PM
May 2, 2018 01:25PM
May 2, 2018 06:18AM
Apr 26, 2018 06:16AM
Apr 19, 2018 05:28PM Form S-1/A HEAT BIOLOGICS, INC.
Apr 18, 2018 07:29AM
Mar 30, 2018 06:16AM
Mar 26, 2018 07:07AM
Feb 28, 2018 06:06AM
Feb 20, 2018 01:04PM
Feb 14, 2018 07:20AM
Dec 7, 2017 07:08AM Heat Biologics (HTBX) Granted FDA Guidance at Type C Meeting for HS-110 Clinical Trial
Nov 22, 2017 04:12PM

66,602 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All